The Rs 65-lakh crore consumer market in India, now the fourth-largest in the world, is poised for transformative shifts over ...

GIFT Nifty traded up by 26 points or 0.10% at 24,773.50 indicating a positive opening for domestic indices NSE Nifty 50 and ...

British drugmaker GSK on Thursday announced positive results from its mid-stage trial of its seasonal influenza vaccine programme using the messenger RNA (mRNA) technology, saying it would now ...

British drugmaker GSK said on Wednesday its experimental herpes simplex virus (HSV) vaccine candidate failed to meet the main ...

India's para-athletes have broken their previous record by winning 29 medals at the Paris Paralympics, surpassing the 19 medals won in Tokyo. Key achievements include Avani Lekhara's second gold ...

a new study has found that cases of tuberculosis are a lot more prevalent among healthcare workers in India in comparison to the general population. The analysis of 10 separate studies conducted ...

We also explore and comment on the aspects of consumer drug plan design that contribute ... To obtain rebate estimates, we used SSR Health LLC’s US Brand Rx Net Pricing Tool.

GSK anticipates regulatory submission for Europe and Canada in 2025, as per a previous earnings report. Image credit: Shutterstock / OleksSH. GSK’s asthma drug Nucala (mepolizumab) has met the primary ...

GSK has announced a 50/50 joint venture with ... six-in-one combination paediatric vaccine to help protect children in India and other developing countries from polio and other infectious diseases.

Stocks like Mankind Pharma, Indian Energy Exchange, NHPC, BGR Energy Systems, PDS, Jindal Stainless, and Medi Assist ...

Global healthcare company GlaxoSmithKline Pharmaceuticals Ltd on Tuesday (September 3) said it has received an income tax refund of ₹222.23 crore for the assessment year 2022-23, following an order ...